BCD Bioscience
Steven Watkins is an accomplished professional with extensive experience in the biotechnology and food science sectors. Currently serving as CEO of Verso Biosciences since July 2016, Watkins is also the Lead Strategist and Technical Advisor for The Periodic Table of Food Initiative and holds dual roles as President and Chief Executive Officer at one.bio. Prior to these positions, Watkins was Chief Technology Officer at Metabolon, Senior Visiting Scientist at Harvard School of Public Health, and Chief Technology Officer at Tethys Bioscience. Watkins' entrepreneurial spirit is evident from the tenure as CEO, Founder, and CSO of Lipomics Technologies. Academically, Watkins earned a Ph.D. in Food Science and Technology from the University of California, Davis, and a B.S. from Cornell University.
This person is not in any offices
BCD Bioscience
BCD Bioscience is a fast-paced, emerging biotechnology spinout from UC Davis creating ingredients for food and biopharmaceutical applications. They use proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function.